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Abstract
Objectives—Women with gestational diabetes mellitus (GDM) may be able to reduce their risk 
of recurrent GDM and progression to type 2 diabetes mellitus through lifestyle change; however, 
there is limited population-based information on GDM recurrence rates.
Methods—We used data from a population of women delivering two sequential live singleton 
infants in Massachusetts (1998–2007) to estimate the prevalence of chronic diabetes mellitus 
(CDM) and GDM in parity one pregnancies and recurrence of GDM and progression from GDM 
to CDM in parity two pregnancies. We examined four diabetes classification approaches; birth 
certificate (BC) data alone, hospital discharge (HD) data alone, both sources hierarchically 
combined with a diagnosis of CDM from either source taking priority over a diagnosis of GDM, 
and both sources combined including only pregnancies with full agreement in diagnosis. 
Descriptive statistics were used to describe population characteristics, prevalence of CDM and 
GDM, and recurrence of diabetes in successive pregnancies. Diabetes classification agreement 
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was assessed using the Kappa statistic. Associated maternal characteristics were examined through 
adjusted model-based t tests and Chi square tests.
Results—A total of 134,670 women with two sequential deliveries of parities one and two were 
identified. While there was only slight agreement on GDM classification across HD and BC 
records, estimates of GDM recurrence were fairly consistent; nearly half of women with GDM in 
their parity one pregnancy developed GDM in their subsequent pregnancy. While estimates of 
progression from GDM to CDM across sequential pregnancies were more variable, all approaches 
yielded estimates of ≤5 %. The development of either GDM or CDM following a parity one 
pregnancy with no diagnosis of diabetes was <3 % across approaches. Women with recurrent 
GDM were disproportionately older and foreign born.
Conclusion—Recurrent GDM is a serious life course public health issue; the inter-pregnancy 
interval provides an important window for diabetes prevention.
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Introduction
Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance leading to 
hyperglycemia with onset or first recognition during pregnancy, is a common complication 
of pregnancy [1]. It is associated with increased maternal and infant complications, 
including increased cesarean delivery [2–5], infant macrosomia [3–5], respiratory distress 
[6], neonatal hypoglycemia [4], and perinatal mortality [4]. While some 5–10 % of women 
have abnormal hyperglycemia that persists after delivery (reflecting preexisting diabetes or 
impaired glucose tolerance and/or impaired fasting glucose), most women revert to normal 
carbohydrate metabolism [1, 7]. However, women with a history of GDM have a 30–84 % 
increased risk of developing GDM in subsequent pregnancies [8] and a 35–60 % chance of 
developing diabetes in the next 10–20 years, usually type 2 diabetes [9, 10].
Women with GDM may be able to reduce their risk of recurrent GDM and progression to 
type 2 diabetes mellitus through lifestyle change. A number of randomized trials have 
demonstrated that medication [11–13] and/or weight loss [12, 13] and increased physical 
activity [13] reduce the risk of type 2 diabetes in high-risk individuals, including women 
with previous GDM [14]. However, very limited epidemiological information exists on the 
recurrence rates for GDM; the few extant studies use very different types of samples, 
methodologies and GDM criteria and then report greatly varying rates of GDM recurrence 
[5, 8, 15–19]. In a recent study from 20 Utah hospitals from 2002 to 2010, Boghossian et al. 
[5] used medical records to identify cases of GDM. Their results indicated that the risk of 
developing recurrent GDM was 65 % overall and 62 % among women with sets of parity 1 
and 2 births. In contrast, Getahun et al. [17], using the Southern California Kaiser 
Permanente data base from 1991 to 2008, reported a 41 % GDM recurrence rate and an 
increased GDM prevalence following a prior GDM pregnancy compared to a prior non-
affected pregnancy (OR = 13.2, 95 % CI 12.0–14.6). To our knowledge, the only U.S. 
population-based study [15] was conducted more than 20 years ago, using data from 
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Washington state birth certificate (BC) data from 1984 to 1991. McGuire et al. [15] found 
that the risk of developing GDM in the pregnancy following two GDM-affected pregnancies 
was greatly increased compared with women without GDM in the previous two pregnancies 
(OR = 23.2, 95 % CI 17.2–31.2). A more recent population-based study from New South 
Wales Australia from 2001 to 2008 reported a GDM recurrence rate of 41 % [19]. 
Progression of GDM to chronic diabetes mellitus (CDM) across sequential pregnancies is 
even less well studied, especially in population-based data [10]. More current and larger, 
U.S. population-based estimates of GDM prevalence and the incidence of recurrence and 
progression to type 2 diabetes are needed to estimate the potential public health impact of 
diabetes prevention interventions, especially in light of increasing obesity, type 2 diabetes, 
and GDM [20–25].
The primary sources for surveillance of diabetes in pregnancy in the U.S. are BC and 
hospital discharge (HD) records; these sources have sometimes been combined to increase 
sensitivity [26, 27]. Detailed comparisons of the agreement of chronic diabetes diagnoses 
(CDM), which includes type 1 and type 2 diabetes, and GDM between these two sources or 
combinations of the two sources have not been performed.
In this study, we used a population of women delivering two sequential live singleton infants 
in Massachusetts (1998–2007) to examine the prevalence of CDM and GDM in parity one 
pregnancies, the recurrence rate of GDM, and the progression from GDM to CDM between 
parity one and parity two pregnancies. We examined and contrasted four different 
approaches to classifying women’s diabetes status: BC data alone, HD data alone, both 
sources hierarchically combined in which a diagnosis of CDM from either source took 
priority over a diagnosis of GDM, and both sources combined [18] in which only 
pregnancies with complete agreement in diagnosis between sources were included. We then 




We used a population-based cohort of pregnant women who delivered a live birth from 1998 
through 2007 in Massachusetts derived from the Pregnancy to Early Life Longitudinal 
(PELL) data system, a longitudinally linked data system of mothers and their children from 
birth to early childhood [28]. Deterministic and probabilistic methodologies were used to 
link records from the data sets. Consecutive birth files were linked to identify sequential 
pregnancies in individual women. A more detailed description of the PELL data system is 
described elsewhere [28].
For this analysis, we first selected sets of two sequential pregnancies in our dataset to 
individual women which met the following criteria: both pregnancies resulted in a live 
singleton delivery in a Massachusetts hospital to a Massachusetts resident and BC and HD 
records could be linked for both deliveries (n = 181,030 sets of births). We then restricted 
the sample to only first and second parity births (n = 141,233 sets of births). We then 
subjected the two birth sets to closer scrutiny to assure that all deliveries were truly 
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sequential using the following criteria: (1) absence of a date of last live birth in the first 
parity pregnancy; (2) exact or close agreement between the date of birth of the first parity 
pregnancy and the date of last live birth for the second parity pregnancy; (3) the parity 
numbers from the BC for the two pregnancies were one and two or parity numbers could be 
inferred if they didn’t match one and two (for example, if parity numbers were one and 
something other than two, but the date of last live birth for the second parity pregnancy 
matched the date of delivery for the first parity pregnancy); and (4) the time between the two 
deliveries was plausible. Questionable sets were deleted (n = 6563). Based on these criteria, 
we identified 134,670 record sets that we judged to be first and second pregnancies of parity 
one and two.
Diabetes Definition and Classification
Data from PELL HD records and BC records were used to identify potential cases of GDM 
and CDM during pregnancy. Up to nine ICD 9-CM discharge codes could be listed for a 
delivery hospitalization. Hospital discharge ICD 9-CM codes for CDM were 648.0 (CDM 
excluding GDM), and 250.0–250.9 [CDM without complications (250.0) or with 
complications (250.1–.9)]. The ICD 9-CM code for GDM was 648.8. On the Massachusetts 
1996 standard certificate of live birth either or both of the CDM or GDM boxes could be 
checked. A separate check box for “no diabetes” is not available. For both BC and HD 
records, in the absence of an indication of diabetes (no diabetes box checked or no 
ICD-9CM code for diabetes) it was assumed that the pregnancy was not complicated by 
diabetes.
GDM and CDM diagnoses were classified based on data source: BC alone, HD alone, and 
BC and HD combined. For BC alone and for HD alone, if an individual pregnancy had 
diagnoses for both CDM and GDM, CDM was the default diagnosis. When BC and HD 
were combined, two different approaches were taken. In the first, referred to as the 
“combined hierarchical” approach, the presence of a CDM diagnosis from either source (HD 
or BC) resulted in the pregnancy diagnosis categorized as CDM; among the remaining 
pregnancies, a GDM diagnosis from either source resulted in a pregnancy diagnosis of 
GDM; and those pregnancies without a diagnosis of diabetes from either source were 
categorized as “no diabetes.” In the second, referred to as the “combined full agreement” 
approach, only records with complete agreement between HD and BC diagnoses were 
included; all other records (deliveries with diabetes status ‘both’ in either the BC or HD 
record of either delivery, and deliveries for which the BC and HD diabetes status do not 
agree for both deliveries) were excluded from analysis (N = 4982 records (3.6 %)).
Analysis
Descriptive statistics were used to describe population characteristics, prevalence of CDM 
and GDM, and recurrence of diabetes in pregnancy. Results from each of the four diabetes 
classification methods were compared. The extent of diabetes classification agreement was 
assessed using the Kappa statistic and plausibility of sequential diagnoses. (Kappa statistics 
from 0.00–0.20, 0.21–0.40, 0.41–0.60; 0.61–0.80; to 0.81–1.00 are considered slight, fair, 
moderate, substantial, and almost perfect comparability respectively [29]). Finally, selected 
maternal characteristics were compared across eight categories of diabetes status that 
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grouped cases with and without GDM and CDM in parity one and two births (No DM/No 
DM, No DM/GDM, No DM/CDM, GDM/No DM, GDM/GDM, GDM/CDM, CDM/No DM 
or GDM, CDM/CDM), with a focus on women with recurrent GDM and those without, 
using Chi square tests and model-based t tests, adjusted for multiple comparisons. The 
adjustments were made by a method described by Jin and Wang [30] for categorical 
variables and by the Tukey–Kramer method [31] for numeric variables; an adjusted p value 
of <0.05 was considered statistically significant. Statistical analyses were performed using 
SAS software V.9 (SAS Institute Inc., Cary, NC) for Windows.
The study protocol was reviewed and approved or exempted by the institutional review 
boards (IRBs) of the Centers for Disease Control and Prevention and the Massachusetts 
Department of Public Health.
Results
There were 134,670 Massachusetts resident women with two sequential deliveries in 
Massachusetts hospitals with parity one and two births in 1998–2007. Characteristics of 
these women are described in Table 1. Based on information from parity one births, the 
median maternal age was 29 years, and nearly 10 % of women were age 35 or older. Over 
two-thirds had over 12 years of education (68.6 %), almost three-fourths had private 
insurance (73.5 %), and nearly 20 % were foreign born.
Diabetes Classification
There was substantial agreement on diabetes classification between HD records and BC, 
primarily due to the high number of women with no DM in either pregnancy in both data 
sets. The Kappa statistic for diabetes diagnostic agreement was 0.69 for parity one and 0.69 
for parity two pregnancies, with 98.2 and 97.6 % concordance respectively. If women with 
no DM for both BC and HD are excluded, there is only slight agreement on GDM 
classification, the Kappa statistic decreases to 0.09 in parity one and to 0.05 in parity two 
pregnancies and the concordance level drops to 52.2 and 70.6 %. Among parity one 
pregnancies with a diagnosis of GDM by HD alone, only 60.8 % also had a diagnosis of 
GDM by BC; among those with a diagnosis of CDM by HD alone, 63.3 % also had a 
diagnosis CDM by BC; and of those with no diagnosis of DM by HD alone, 99.4 % had no 
diagnosis of CDM by BC (Table 2). The percentage of pregnancies with a diabetes diagnosis 
determined by BC that also had the same diagnosis by HD were 79.4, 63.2, and 99.0 % for 
GDM, CDM, and no diabetes, respectively. Findings were similar for parity two 
pregnancies.
Using the combined hierarchical approach, 4102 women were classified as having GDM in 
the parity one pregnancy and the source of GDM diagnosis was as follows: 31 % had a 
diagnosis of GDM from the HD and not the BC, 13 % from the BC and not the HD, and 57 
% had a diagnosis from both sources (Table 3). Of the 1030 women classified as having 
CDM in the parity one pregnancy, 18 % had a diagnosis of CDM from the HD and not the 
BC, 43 % had a diagnosis from the BC and not the HD, and 39 % had a diagnosis from both 
sources. A similar pattern was seen for the parity two pregnancies.
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The four diabetes classification approaches provide varying estimates of GDM and CDM 
prevalence in parity one and two pregnancies. According to HD alone, 2.8 % of parity one 
pregnancies were complicated by GDM and 0.4 % were complicated by CDM (Table 4). 
When diabetes diagnosis in the first pregnancy was examined using BC alone, the estimate 
was slightly lower for GDM (2.2 %) but similar for CDM (0.4 %). Diabetes prevalence 
estimates based on the combined hierarchical approach were higher (3.0 % GDM; 0.8 % 
CDM) than those using either the BC or HD source alone. Diabetes prevalence estimates 
based on the combined full agreement approach were lower than in each of the three other 
approaches (1.8 % GDM; 0.3 % CDM). Up to 1.7-fold differences in initial GDM rates and 
2.3 fold differences in initial CDM rates were noted across the different classification 
approaches.
Comparisons across the four classification approaches for parity two pregnancies were 
similar to comparisons for parity one pregnancies. All diabetes prevalence estimates for 
parity two were slightly higher than for parity one, regardless of the categorization approach 
(Table 4).
Diabetes in Sequential Pregnancies
Despite variations in diabetes estimates across classification methods, estimates of GDM 
recurrence across sequential pregnancies among women with GDM in the parity one 
pregnancy were fairly consistent across approaches, and ranged from 38.4 (BC alone) to 
47.7 % (combined hierarchical) (Table 5). Estimates of progression from GDM in the parity 
one pregnancy to CDM in the parity two pregnancy ranged from 2.4 (combined full 
agreement) to 5.1 % (combined hierarchical). Among women with no diabetes in the parity 
one pregnancy, estimates of GDM in the parity two pregnancy ranged from 1.5 (combined 
full agreement) to 2.6 % (combined hierarchical). Very few women with no diabetes in the 
parity one pregnancy had a diagnosis of CDM in the parity two pregnancy (0.0 % using 
combined full agreement and 0.4 % using combined hierarchical). Because diabetes 
prevalence increased over the study period, we repeated our analysis using data from 2003 
to 2007 only; the resultant patterns of diabetes diagnosis across pregnancies were similar to 
those using the full multi-year data set.
Examination of diabetes diagnosis in the parity two pregnancy among women with a 
diagnosis of CDM in the parity one pregnancy revealed evidence of significant 
misclassification in three of the classification approaches; using HD alone, 24.7 % had no 
diagnosis of diabetes or had GDM in the parity two pregnancy, using BC alone, 53.5 % had 
no diagnosis of diabetes or had GDM in the parity two pregnancy, and using combined 
hierarchical approach, 42.3 % had no diagnosis of diabetes or had GDM in the parity two 
pregnancy. In contrast, when using the combined full agreement approach, only 9.8 % had 
no diagnosis of diabetes or GDM in the parity two pregnancies (Table 5). Further 
examination of data using the combined hierarchical approach revealed that for women with 
CDM in the parity one pregnancy and no diabetes in the parity two pregnancy, nearly half 
(42 %) had had the diagnosis of CDM from the BC and no diagnosis of diabetes from the 
HD. For women with CDM in the parity one pregnancy and GDM in the parity two 
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pregnancy, there was no single particular combination that accounted more than 14 % of 
women in this category (data not shown).
Maternal Characteristics
Patterns of diabetes diagnosis across pregnancies varied by selected maternal characteristics 
(Table 6). Women with No GDM or CDM in either pregnancy (group 1) were younger, less 
educated and had a different racial distribution than women in most other GDM/CDM 
diagnosis categories. They were more often White and less often Asian. Among women with 
GDM in the parity one pregnancy, those with recurrent GDM (group 5) were older at parity 
one than those who did not have GDM (group 4) in the parity two pregnancy (p < 0.001) and 
were more likely to be foreign born (p < 0.05); and the same pattern was seen for those 
women with either recurrent GDM or CDM together (groups 5 and 6) (data not shown).
Discussion
In this population-based study, we examined patterns in diabetes across consecutive 
pregnancies using different approaches to disease categorization. We found that estimates of 
GDM recurrence were fairly consistent, regardless of the categorization approach; nearly 
half of women with GDM in their parity one pregnancy developed GDM in their subsequent 
pregnancy. While estimates of progression from GDM to CDM across sequential 
pregnancies were somewhat variable, all four approaches yielded estimates of ≤5 %. 
Similarly, the development of either type of diabetes (GDM or CDM) following a parity one 
pregnancy with no diagnosis of diabetes was rare (<3 %) in all approaches.
There are few published studies of GDM recurrence rates. Our estimated recurrence rates 
(34–48 %) are similar to the ~40 % recurrence rates noted in the study of Kaiser Permanente 
enrollees [17] and the large population-based study in New South Australia [19], as well as 
in White non-Hispanic mothers from several non-population-based studies conducted within 
and outside of the U.S [8]. In contrast, the current study finding is much lower than the 62 % 
recurrence rate reported in the recent Utah hospitals’ case series study [5].
Because GDM is believed to be a manifestation of increased insulin resistance and 
decreased beta cell compensation for insulin resistance [32–34], one might expect the 
recurrence rate to be very high. Several factors could have contributed to the finding that 
over half of women with GDM in the first pregnancy did not have GDM in the second 
pregnancy. First, women with a history of GDM may have modified their lifestyle between 
pregnancies or during their second pregnancy, resulting in weight loss, less weight gain 
during pregnancy, improved nutrition and/or increased physical activity. Second, the finding 
could reflect errors in the initial GDM diagnosis on the BC or HD records (e.g. an over-
estimation in initial GDM diagnosis). For example, providers may record a diagnosis of 
GDM or possible GDM in the medical records of women with elevated blood glucose levels 
even if a glucose tolerance test did not meet criteria for GDM; and clinicians may use 
different standards for GDM diagnoses. Alternatively, a diagnosis of GDM in one 
pregnancy may not be a perfect predictor of progression toward type 2 diabetes; progression 
toward type 2 diabetes might not be a linear process, especially when observed over short 
periods of time. The initial GDM diagnosis may still reflect some elevated future risk, 
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though not enough to merit a GDM diagnosis in the subsequent pregnancy. Finally, the 
pattern we observed could reflect selection bias if women at highest risk for recurrence were 
less likely than lower risk women to have a second pregnancy during our study interval.
Our lower estimates of progression from GDM to CDM using combined full agreement (2.4 
%) and HD alone (3.1 %) are similar to the estimate of Khambalia et al. [19]. The higher 
estimates of CDM progression based on BC data may be less reliable and prone to over-
estimation. The combined full agreement approach likely has lower sensitivity because of 
the high percentage of records excluded, but its specificity is superior to the other 
approaches. New CDM diagnoses in parity two pregnancies without prior GDM indications 
were rare.
As evidence has shown that weight loss after pregnancy has the potential to reduce a 
woman’s future risk for type 2 diabetes [35], women with a GDM-affected pregnancy 
should be encouraged to continue their lifestyle modification after pregnancy to return to 
their healthy pre-pregnancy BMI, and if they were overweight or obese when entering 
pregnancy to continue to lose weight to prevent postpartum weight retention or entering in 
the next pregnancy obese. Future studies to better understand the etiology of those who do 
and do not develop GDM in a subsequent pregnancy or progress to type 2 diabetes would be 
useful for public health efforts in diabetes prevention.
Examination of methodological variations in GDM classification was a planned, critical part 
of this study, though we found more substantial variations than we had initially anticipated–
which in part led us to utilize alternative combinational approaches, including the combined 
full agreement approach. Two major methodological findings are of particular note; we 
found large variations in initial classification of diabetes status between BC and HD records 
and evidence of substantial misclassification in CDM diagnosis. First, variation up to 166 % 
in GDM classification by source is problematic for surveillance. Lydon-Rochelle et al. [27] 
and others have noted that clinical risk factors for poor pregnancy outcomes are generally 
more often documented in the HD records than in BC records. Here we document that 31 % 
of GDM cases identified in the HD records were not noted in the BC data. Since use of BC 
data for state (and national) estimates of GDM is wide-spread, our findings suggests caution 
in its usage for that purpose as it likely substantially under-estimates GDM prevalence.
Second, this study detected serious CDM measurement issues among pregnant women, 
using information either from the BC or HD or their combinations. Potential CDM over-
identification and implausible sequential birth diagnoses were both widely noted (e.g., CDM 
in the parity one pregnancy and no CDM or GDM in the parity two pregnancy). In 
particular, the current study found that the BC alone or in combined hierarchical approach 
had the largest number of implausible diagnosis combinations. This finding is also 
consistent with an earlier validation study conducted by Lydon-Rochelle and colleagues in 
which medical records in Washington State were compared with data from BC, HD, and a 
combination of these sources and showed a substantial over estimation of CDM [27]. Their 
medical record-based estimate of CDM was 1.1 % while that based on combined data from 
BC and HD was 1.7 %, an overestimation of more than 50 %. When combined with the 
findings of the current study, the Lydon-Rochelle et al. data suggest that combining data 
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from BC and HD to determine CDM diagnosis may be especially problematic and could 
result in an increase in false positive diabetes diagnoses and an overestimation of CDM 
prevalence during pregnancy.
More generally, BC and HD data may not be suitable sources of data for identifying or 
monitoring CDM among population-based cohorts of women giving birth. The 
inconsistencies across data sources noted here may simply reflect the widespread uncertainty 
with initial recording of CDM/GDM diagnoses in parity one births. Some of the GDM 
associated births may reflect undiagnosed CDM cases among women who had never have 
been preconceptionally monitored for diabetes prior to entry into prenatal care. Interestingly, 
most of the other sequential GDM researchers chose restrictive methodologic solutions to 
avoid dealing directly with any potential CDM misclassification problems; either by 
excluding or omitting all CDM cases from their analyses [17] or by assuming CDM 
stability/chronicity and ignoring any implausible changes in subsequent diagnoses [5]. 
Known CDM/GDM diagnostic confusion during pregnancy is manifest in our public 
surveillance data systems.
The characteristics of women with sequential GDM, older maternal age and higher foreign-
born prevalence, is consistent with the findings of Khambalia and colleagues, who identified 
maternal age >35 and maternal country of birth Middle East/North Africa and Asia as risk 
factors for recurrent GDM, as well as for pregnancy associated hypertension, large for 
gestational age/preterm birth in the first pregnancy, and longer birth interval [19]. The 
maternal characteristics for GDM recurrence seem consistent with the major risk factors for 
GDM itself.
Our study has several limitations. First, the older age, better educated demographics of 
Massachusetts births may restrict the generalizability of the study findings. Second, 
identifying the first and second sequential delivery combinations may be subject to error; 
some of our birth chains may not actually reflect parity one and parity two. Third, there is no 
“no diabetes” diagnostic category on either the BC or the HD record, it is a residual 
classification and may be subject to error. Fourth, we were not able to validate the study’s 
administrative record GDM/CDM diagnoses with medical record reviews—and so could not 
calculate the sensitivity, specificity, positive predictive values, and negative predictive 
values of the four categorization approaches. Further, we cannot determine if there are any 
differentially misclassification biases across parity that might further alter our sequential 
GDM estimates. Moreover, the right censoring of the study period may have limited the 
current analysis to women with shorter inter-pregnancy intervals, excluding the full fertility 
experiences of the women who have not finished their child-bearing efforts, and hence 
potentially under-estimating the sequential GDM/CDM prevalence. In addition, we did not 
have data on maternal body mass index, which is an important predictor of both GDM and 
CDM. Strengths of this study include that it is population based and that the sample is large 
enough to examine combinations of diabetes diagnoses across pregnancies.
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In a MA population-based cohort, using a variety of data sources and GDM/CDM 
classification approaches, we consistently found that women with GDM in their parity one 
pregnancy have a risk of recurrence approaching 50 % and 2–5 % risk of progression to 
CDM in their parity two pregnancy. The risk of GDM or CDM in the parity two pregnancy 
in the absence of a diagnosis of diabetes in the initial pregnancy is very low. Substantial 
variations in diabetes classification surveillance measures exist. There was only slight 
agreement on GDM classification between HD and BC records, suggesting the potential for 
under-reporting of GDM from either data base alone. Further, substantial levels of CDM 
diagnostic implausibility and misclassification from BC and HD data, alone or in 
hierarchical combinations, suggest that these data sources may not be suitable for studying 
chronic diabetes in pregnancy. Women with sequential GDM pregnancies are older and 
more likely foreign born, similar to risk factors for GDM itself. GDM recurrence remains a 
serious life course public health issue in this era of obesity and diabetes epidemics. Given 
that over half of women with GDM diagnosis in their first pregnancy have no DM diagnosis 
in the subsequent pregnancy suggests that the inter-conception period may therefore provide 
an important window for diabetes prevention. Clinical and lifestyle interventions may be 
efficacious for some women. Future studies from this series will examine the impact of 
GDM recurrence on maternal and birth outcomes.
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What is already known on this subject?
Gestational diabetes mellitus (GDM) is increasing in the US. Lifestyle changes can 
reduce risks of recurrent GDM and progression to type 2 chronic diabetes mellitus 
(CDM). However, few published studies describe recurrence rates across pregnancies.
What this study adds?
This study provides population-based estimates of GDM recurrence in Massachusetts. 
Nearly 50 % of women with GDM in their parity one pregnancy developed GDM in their 
next pregnancy, and under 5 % progressed to CDM. However, this study found limited 
agreement in GDM and CDM status across different diabetes classification approaches 
using birth certificate and hospital discharge records.
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Table 1
Maternal characteristics of study population at parity one delivery among 134,670 sets of sequential first and 













High school (12 years) 15,915 11.83
Some college (<4 years) 26,321 19.57
≥4 years of college 26,511 19.71
65,742 48.88















Free care 462 0.34






Year of second delivery
1998–1999 2234 1.66
2000–2001 22,627 16.80
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Table 2
Diabetes diagnosis from birth certificate records compared to diabetes diagnosis from hospital discharge 
records for sets of sequential parity one pregnancy (N = 134,670) and parity two pregnancy (N = 134,670), 
Massachusetts 1998–2007
Hospital discharge diagnosis (N, column %)
Birth certificate diagnosis No DM GDM CDM Both Total
Parity one pregnancy
No DM 129,538 (99.4) 1266 (33.2) 90 (16.3) 11 (28.9) 130,905 (97.2)
GDM 515 (0.4) 2321 (60.8) 72 (13.1) 14 (36.8) 2922 (2.2)
CDM 142 (0.1) 55 (1.4) 349 (63.3) 6 (15.8) 552 (0.4)
Both GDM/CDM 68 (0.1) 176 (4.6) 40 (7.3) 7 (18.4) 291 (0.2)
Total 130,263 (100.0) 3818 (100.0) 551 (100.0) 38 (100.0) 134,670 (100.0)
Parity two pregnancy
No DM 127,955 (99.2) 1524 (30.5) 127 (19.6) 8 (33.3) 129,614 (96.2)
GDM 807 (0.6) 3122 (62.6) 106 (16.3) 10 (41.7) 4045 (3.0)
CDM 174 (0.1) 104 (2.1) 382 (58.9) 2 (8.3) 662 (0.5)
Both GDM/CDM 70 (0.1) 241 (4.8) 34 (5.2) 4 (16.7) 349 (0.3)
Total 129,006 (100.0) 4991 (100.0) 649 (100.0) 24 (100.0) 134,670 (100.0)
Kappa = 0.69, 95 % CI = 0.68–0.70
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Table 3
Diabetes category based on combined hierarchical approach, by source of diagnosis, for parity one pregnancy 
and parity two pregnancy, Massachusetts 1998–2007
Diabetes status based on combined hierarchical categorization
(N, column %)
Parity 1 pregnancy
Source of diabetes diagnosis GDM (N = 4102) CDM (N = 1030)
HD 1266 (31) 187 (18)
BC 515 (13) 441 (43)
Both HD and BC 2321 (57) 402 (39)
Parity 2 pregnancy
Source of diabetes diagnosis GDM (N = 5453) CDM (N = 1262)
HD 1524 (28) 251 (20)
BC 807 (15) 589 (47)
Both HD and BC 3122 (57) 422 (33)
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Table 4
Prevalence of diabetes diagnoses for parity one and parity two pregnancy by four approaches using hospital 
discharge and birth certificate records, Massachusetts 1998–2007
Diabetes status HD alone BC alone Combined BC-HD hierarchical Combined BC-HD full agreement
N % N % N % N %
Parity one pregnancy
No DM 130,263 96.7 130,905 97.2 129,538 96.2 129,538 98.0
GDM 3818 2.8 2922 2.2 4102 3.0 2321 1.8
CDM 551 0.4 552 0.4 1030 0.8 349 0.3
Both GDM/CDM 38 0.0 291 0.2 7 0.0
Total 134,670 100.0 134,670 100.0 134,670 100.0 132,215 100.0
Parity two pregnancy
No DM 129,006 95.8 129,614 96.2 127,955 95.0 127,955 97.3
GDM 4991 3.7 4045 3.0 5453 4.0 3122 2.4
CDM 649 0.5 662 0.5 1262 0.9 382 0.3
Both GDM/CDM 24 0.0 349 0.3 4 0.0
Total 134,670 100.0 134,670 100.0 134,670 100.0 131,463 100.0
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Table 5
Prevalence of diabetes status from parity one to parity two pregnancy by four approaches to assign diabetes 
status, Massachusetts 1998–2007
Approach for assigning DM status (N, column %)




N 134,608 134,155 134,670 129,688
GDM No DM 1922 (50.4) 1673 (57.9) 1938 (47.2) 964 (53.4)
GDM 1769 (46.4) 1108 (38.4) 1955 (47.7) 798 (44.2)
CDM 120 (3.1) 107 (3.7) 209 (5.1) 44 (2.4)
No DM No DM 127,009 (97.5) 127,636 (97.6) 125,737 (97.1) 125,737 (98.5)
GDM 3134 (2.4) 2816 (2.2) 3342 (2.6) 1866 (1.5)
CDM 107 (0.1) 280 (0.2) 459 (0.4) 0 (0.0)
CDM No DM 63 (11.5) 210 (39.3) 280 (27.2) 13 (5.3)
GDM 72 (13.2) 76 (14.2) 156 (15.1) 11 (4.5)
CDM 412 (75.3) 249 (46.5) 594 (57.7) 220 (90.2)
a
Excludes 62 deliveries with diabetes status ‘both’ in the hospital discharge record of either delivery
b
Excludes 515 deliveries with diabetes status ‘both’ in the birth certificate record of either delivery
c
Excludes 9892 deliveries with either (1) diabetes status ‘both’ in either the BC or HD record of either delivery, or (2) deliveries for which the BC 
and HD diabetes status do not agree for both deliveries
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Table 6
Selected characteristics of women by various sequential GDM/CDM combinations, using combined 
hierarchical approach for diabetes classification, Massachusetts 1998–2007 (N = 134,670)




























N 125,737 3342 459 1938 1955 209 436 594
Age at parity one birth (%)
<20 12.5 8.3 9.6 6.1 3.2 4.8 7.6 5.7
20–24 16.5 16.1 17.2 15.2 11.8 11.5 13.1 14.1
25–29 29.1 30.4 26.1 32.0 30.7 29.7 28.7 27.1
30–34 32.4 34.1 32.9 33.8 38.7 36.4 36.2 38.4
35–39 9.0 10.0 13.3 12.0 13.9 16.3 14.0 13.3
40+ 0.6 1.1 0.9 1.0 1.6 1.4 0.5 1.3
Mean age1 27.5 28.3a 28.2a 28.7a,b 29.7a,b,c,d 29.6a,b,c,d 28.9a 29.1a,b
Birth interval (years) 2.8 3.2a 3.2a 2.7a,b,c 2.7a,b,c 3.0a 2.8b,c 2.7b,c
Education at parity one birth (%)
<HS (<12 years) 12.5 8.3 9.6 6.1 3.2 4.8 7.6 5.7
HS (12 years) 16.5 16.1 17.2 15.2 11.8 11.5 13.1 14.1
Some college (13–15 years)2 29.1 30.4 26.1 32.0 30.7 29.7 28.7 27.1
4 + years of college (16 + years) 32.4 34.1a 32.9 33.8a 38.7a,b,c 36.4a 36.2b,e,f 38.4a,b
Race/ethnicity at parity one birth (%)
Hispanic 9.8 9.5 17.0 7.3 8.1 13.9 14.3 10.4
White 77.2 70.8 59.6 72.9 72.0 63.5 63.4 73.9
Black 5.4 6.1 11.6 6.4 5.8 11.1 9.2 8.9
Asian 5.8 11.6 8.7 11.7 12.6 10.6 11.3 5.9
Native American 1.9 2.0a 3.1a,b 1.7a,c 1.5a,c 1.0a,d,e 1.8a,d,e 0.8a,b,c,d,e,
Foreign born (%) 19.3 26.4a 27.5a 25.3a 28.2a,d 30.6a 28.4a 17.2
Payment source at parity one birth (%)
Private2 73.4 73.0 67.5a 77.0a,b,c 78.6a,b 76.6c 73.4 71.5
Public 25.9 26.1 31.4 22.1 20.5 23.0 25.5 26.9
Self-pay 0.4 0.5 0.4 0.6 0.6 0.5 0.7 0.7
Free care 0.3 0.4 0.7 0.3 0.4 0.0 0.5 0.8
a
Different from group 1, p<.05
b
Different from group 2, p<.05
c
Different from group 3, p<.05
d
Different from group 4, p<.05
e
Different from group 5, p<.05
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f
Different from group 6, p<.05
1
Comparison of Mean Age
2
Comparison of Public versus Private payment source only
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